Coughing precipitated by bordetella pertussis infection

Matthew Hewitt, Brendan J. Canning

Research output: Contribution to journalArticlepeer-review

Abstract

Infections with the gram-negative bacteria Bordetella pertussis (B. pertussis) have long been recognized as a significant threat to children and are increasingly recognized as a cause of cough in adolescents and adults. Antibiotic therapy, when administered during the virulent stages of the disease, can reduce the duration and severity of symptoms. Unfortunately, there are no effective treatments for the persistent coughing that accompanies and follows the infection. The pathogenesis of B. pertussis infection is briefly reviewed. Also discussed is the evidence supporting the hypothesis that the inflammatory peptide bradykinin may be responsible for the persistent, paroxysmal coughing associated with B. pertussis-initiated illness.

Original languageEnglish (US)
Pages (from-to)S73-S79
JournalLung
Volume188
Issue numberSUPPL.
DOIs
StatePublished - Jan 2010

Keywords

  • Angiotensin-converting enzyme
  • Bradykinin
  • C-fiber
  • C1 esterase inhibitor
  • Neutral endopeptidase

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Coughing precipitated by bordetella pertussis infection'. Together they form a unique fingerprint.

Cite this